Tinidazole

Tinidazole
Clinical data
Trade names	Fasigyn, Simplotan, Tindamax
AHFS/Drugs.com	Monograph
MedlinePlus	a604036
License data	US DailyMed: Tinidazole;
Pregnancy; category	AU: B3;
Routes of; administration	By mouth
ATC code	J01XD02 (WHO) G01AF21 (WHO), J01RA11 (WHO), J01RA13 (WHO), J01RA18 (WHO), P01AB02 (WHO), P01AB53 (WHO), QP51AA02 (WHO);
Legal status
Legal status	AU: S4 (Prescription only); UK: POM (Prescription only); US: ℞-only;
Pharmacokinetic data
Protein binding	12%
Metabolism	Liver (CYP3A4)
Elimination half-life	12–14 hours
Excretion	Urine (20–25%), feces (12%)
Identifiers
	IUPAC name 1-(2-ethylsulfonylethyl)-2-methyl-5-nitro-imidazole;
CAS Number	19387-91-8 ;
PubChem CID	5479;
DrugBank	DB00911 ;
ChemSpider	5279 ;
UNII	033KF7V46H;
KEGG	D01426 ;
ChEMBL	ChEMBL1220 ;
NIAID ChemDB	007940;
CompTox Dashboard (EPA)	DTXSID4023676 ;
ECHA InfoCard	100.039.089
Chemical and physical data
Formula	C8H13N3O4S
Molar mass	247.27 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C;
	InChI InChI=1S/C8H13N3O4S/c1-3-16(14,15)5-4-10-7(2)9-6-8(10)11(12)13/h6H,3-5H2,1-2H3 ; Key:HJLSLZFTEKNLFI-UHFFFAOYSA-N ;
	(verify)

Tinidazole, sold under the brand name Tindamax among others, is a medication used against protozoan infections. It is widely known throughout Europe and the developing world as a treatment for a variety of anaerobic amoebic and bacterial infections. It was developed in 1972 and is a prominent member of the nitroimidazole antibiotic class.

It is on the World Health Organization's List of Essential Medicines.